1. Chang, K. C., Park, C. W. and Lim, J. K., Pharmacological evaluation of GS389, a novel tetrahydroisoquinoline analog, related to higenamine on vascular smooth muscle.Life Sci. 51, 67–74 (1992).
2. Chang, K. C., Lim, J. K. and Park, C. W., Synthesis of higenamine and its cardiovascular effects in rabbit; evidence for β-adrenoceptor agonist.Korean J. Pharmacol. 22, 96–104 (1986).
3. Chang, K. C., Chong, W. S. and Lee, I. J., Efferent pharmacological characteristics of structurally similar benzylisoquinoline analogs, papaverine, higenamine, and GS-389, on isolated rat aorta and heart.Can. J. Physiol. Pharmacol. 72, 327–334 (1994).
4. Chen, F., Sun, S., Kuhn, D. C., Lu, Y., Gaydos, L. J., Shi, X. and Demers, L. M., Tetrandrin inhibits signal-induced NF-kB activation in rat alveolar macrophages.Biochem. Biophys. Res. Commun. 231, 99–102 (1997).
5. Chong, W. S., Lee, Y. S., Kang, Y. J., Lee, D. H., Ryu, J. C., Yun-Choi, H. S. and Chang, K. C., Comparison of inodilator effect of higenamine, YS49, YS51, tetrahydroisoquinoline analogs, and dobutamine in the rat.Korean J. Physiol. Pharmacol. 2, 323–330 (1998).